Depemokimab has been approved by the MHRA as the first and only biologic with twice-yearly dosing to treat asthma and severe ...

Profs Carl Philpott and Claire Hopkins discuss how the MACRO trial challenges long-held assumptions about chronic ...

The 2025 ERS Congress highlighted the emerging challenges and innovations reshaping respiratory medicine, as Ravijyot Saggu ...

Significant unmet needs among people with RA-ILD have been identified in a recent survey, with clear gaps in the services ...

Clinical advantage observed in refractory atopic dermatitis with lebrikizumab plus topical corticosteroids where ciclosporin ...

Managing the future risks of type 2 diabetes and cancer in people with prediabetes should be tailored to the age of ...

Patients with chronic hand eczema often have limited effective and well-tolerated topical treatment options, a real-world ...

A newly developed 10-minute scan could improve the diagnosis and treatment of suspected primary aldosteronism, a UK pilot ...

Dr Chiara Re and Prof Grant Stewart discuss the UK’s first one-stop renal mass biopsy clinic for suspected renal cancer and ...

Regional and demographic variations persist in melanoma BRAF testing and patients with these tumours experience poorer five-year survival.

Artificial intelligence (AI)-enabled electrocardiography (ECG) can accurately predict an individual patient’s risk of future cardiovascular events as well as their short and long-term risk of dying, a ...

The role of extracorporeal membrane oxygenation (ECMO) in oncology intensive care has been questioned after an international study revealed persistently high mortality among cancer patients with ...